Bisbenzisoselenazolonyl derivatives having antineoplastic,...

Details Bisbenzisoselenazolonyl derivatives having antineoplastic,... Bisbenzisoselenazolonyl derivatives having antineoplastic,...

2009-01-09

2010-10-26

Stockton, Laura L. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S359000

Reexamination Certificate

active

07820829

ABSTRACT:
The present invention relates to new bisbenzisoselenazolonyl derivatives of the following general formula (I), wherein R is C4-5-alkylene, and their pharmaceutically acceptable salts. The inventive derivatives have antineoplastic, anti-inflammatory and antithrombotic activities.

REFERENCES:
patent: 4774252 (1988-09-01), Welter et al.
patent: 4873350 (1989-10-01), Welter et al.
patent: 5683863 (1997-11-01), Bergthaller et al.
patent: 2009/0117204 (2009-05-01), Zeng
patent: 1253135 (2000-05-01), None
Osajda et al., Polish Journal of Chemistry, (Jun. 29, 2001), 75(6), pp. 823-830.
Mlochowski et al., “Some Developments in the Chemistry of Selenium Heterocycles and Related Diselenides,” Blue Danube Symposium on Heterocyclic Chemistry: Abstracts and Short Papers, 7th, Eger, Hung., Jun. 7-10, 1998, Paper 120/1-Paper 120/5.
Golub et al., Science, vol. 286, Oct. 15, 1999, pp. 531-537.

Affiliated with

Also associated with

Rating

Bisbenzisoselenazolonyl derivatives having antineoplastic,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bisbenzisoselenazolonyl derivatives having antineoplastic,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bisbenzisoselenazolonyl derivatives having antineoplastic,... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4198678